Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications.

Pharmaceuticals
Matthew D Krasowski

Abstract

In the past twenty years, 14 new antiepileptic drugs have been approved for use in the United States and/or Europe. These drugs are eslicarbazepine acetate, felbamate, gabapentin, lacosamide, lamotrigine, levetiracetam, oxcarbazepine, pregabalin, rufinamide, stiripentol, tiagabine, topiramate, vigabatrin and zonisamide. In general, the clinical utility of therapeutic drug monitoring has not been established in clinical trials for these new anticonvulsants, and clear guidelines for drug monitoring have yet to be defined. The antiepileptic drugs with the strongest justifications for drug monitoring are lamotrigine, oxcarbazepine, stiripentol, and zonisamide. Stiripentol and tiagabine are strongly protein bound and are candidates for free drug monitoring. Therapeutic drug monitoring has lower utility for gabapentin, pregabalin, and vigabatrin. Measurement of salivary drug concentrations has potential utility for therapeutic drug monitoring of lamotrigine, levetiracetam, and topiramate. Therapeutic drug monitoring of the new antiepileptic drugs will be discussed in managing patients with epilepsy.

References

May 1, 1977·Journal of Pharmaceutical Sciences·W H Pitlick, R H Levy
Oct 1, 1992·Clinical Pharmacokinetics·E ReyG Olive
Sep 1, 1991·Therapeutic Drug Monitoring·J M Sailstad, J W Findlay
Jan 1, 1991·British Journal of Clinical Pharmacology·J G LarkinM J Brodie
Jan 1, 1990·Journal of Pharmaceutical and Biomedical Analysis·R A BiddlecombeS C Jeal
Jan 1, 1989·British Journal of Clinical Pharmacology·P J Schechter
Jan 1, 1987·Epilepsia·S BerentB Abou-Khalil
Jul 1, 1988·European Journal of Drug Metabolism and Pharmacokinetics·U TäuberH Matthes
Apr 1, 1988·Journal of Pharmacobio-dynamics·Y SugawaraS Harigaya
Nov 29, 1985·Journal of Chromatography·G E von Unruh, W D Paar
Nov 1, 1984·Clinical Pharmacology and Therapeutics·R H LevyT A Moreland
Nov 1, 1983·Journal of Clinical Pharmacology·R H LevyJ A Tor
Jun 1, 1995·Journal of Clinical Pharmacology·M O WongC E Halstenson
Jan 1, 1994·European Journal of Clinical Pharmacology·M C RouanP Jungers
Aug 1, 1994·Therapeutic Drug Monitoring·T M Annesley, L T Clayton
Jan 1, 1994·Epilepsia·P LloydW Dieterle
May 1, 1993·Journal of Clinical Pharmacology·J F HokeN M Sussman
Mar 1, 1993·Acta Neurologica Scandinavica·M L FriisJ Worm-Petersen
Jan 1, 1995·Epilepsia·M J McLean
Jun 1, 1996·Seizure : the Journal of the British Epilepsy Association·G Schapel, D Chadwick
Apr 1, 1996·Journal of Pharmaceutical and Biomedical Analysis·E ForssbladO Beck
May 23, 1997·Journal of Chromatography. B, Biomedical Sciences and Applications·A Dasgupta, A P Hart
Aug 1, 1997·British Journal of Clinical Pharmacology·E Jacqz-AigrainC Loirat
Aug 1, 1997·Journal of Chromatography. B, Biomedical Sciences and Applications·K MakinoR Oishi

❮ Previous
Next ❯

Citations

Oct 22, 2013·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Zsolt GállTibor Szilágyi
Jun 10, 2011·Therapeutic Drug Monitoring·JoEtta M JuenkeKamisha L Johnson-Davis
Jan 5, 2013·Therapeutic Drug Monitoring·Philip N Patsalos, Dave J Berry
Feb 19, 2016·Expert Opinion on Drug Metabolism & Toxicology·Alberto VerrottiPasquale Parisi
Mar 16, 2017·Biomedical Chromatography : BMC·Lynette EngelbrechtMalie Rheeders
Mar 23, 2018·Journal of the American Geriatrics Society·Heidi TaipaleBritta Haenisch
Jul 28, 2018·Journal of Clinical Pharmacology·Min-Jee KimHyeong-Seok Lim
May 12, 2011·Drug Metabolism and Drug Interactions·Marisol LópezAdrián Llerena
Aug 30, 2014·Annals of the New York Academy of Sciences·Willi CawelloSvetlana Dimova
Apr 17, 2020·European Journal of Hospital Pharmacy. Science and Practice·Maria Mendoza AguileraRaúl Ferrando Piqueres
May 16, 2014·Biomedical Chromatography : BMC·Ewelina SieradzkaHalina Milnerowicz
Dec 6, 2014·Therapeutic Drug Monitoring·Girish S NaikDenise H Fleming
Oct 17, 2014·Pharmaceutical Research·Anroop B NairSree Harsha
Mar 8, 2016·The Mental Health Clinician·Marketa Marvanova
Jul 14, 2018·Paediatric Drugs·Giulia IapadreAlberto Verrotti
Jun 19, 2012·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Renzo GuerriniAnna Rosati
Feb 20, 2013·The International Journal of Pharmacy Practice·Mohammed Al Za'abiIbrahim Al-Zakwani
May 11, 2017·Therapeutic Drug Monitoring·Katarzyna Karaś-RuszczykPawel Mierzejewski
Mar 27, 2020·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Eleni KaratzaVangelis Karalis
Nov 10, 2020·The Journal of Applied Laboratory Medicine·Grace M KronerKamisha L Johnson-Davis
Dec 29, 2020·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Rosa SabençaAna Fortuna
Nov 6, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Karina Sommerfeld-KlattaFranciszek K Główka
Mar 29, 2021·International Journal of Clinical Practice·Manjari AdvaniJaisen Lokhande
Jun 15, 2021·Case Reports in Medicine·Muhammad Nabeel Ghayur
Jul 9, 2021·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Kwabena F M OpuniCharles A Okai

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy
electrophoresis

Software Mentioned

Perucca

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Thérapie
Danièle Bentué-Ferrerle groupe Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique
Expert Opinion on Drug Metabolism & Toxicology
Victor Biton
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
C L CrespiD T Steimel
© 2021 Meta ULC. All rights reserved